Patents and Patent Applications from South Dakota State University


Matches 1 - 50 out of 56 1 2 >
Match Document Document Title
9754733 Method for plasma activation of biochar material  
A method for using plasma to activate biochar is disclosed where reactive gas(es) are excited by external power; biochar set on a sample holder is electrically biased or set at a floating...
US20170241093 SMALL STREAM FISH LADDER  
A fish ladder for small-bodied fishes that is easily portable so as to enable installation and use in a given water course when needed, and relocation at other times. The fish ladder defines a...
9622969 Polymer conjugated protein micelles  
The invention encompasses micelle assemblies, compositions having micelle assemblies, and methods for preparing micelle assemblies and compositions thereof. The invention also encompasses a...
9616021 Method of forming non-immunogenic hydrophobic protein nanoparticles, and uses therefor  
Methods are described for producing non-immunogenic nanoparticles from protein sources by controlling the pH in a nanoprecipitation process. The nanoparticles that are produced by the disclosed...
US20170000144 Process for Manufacture of Milk Permeate Powders  
In one embodiment, the disclosure relates to milk permeate powders, methods of production thereof, and uses of the milk permeate powders. In another embodiment, the disclosure relates to the use...
US20160367683 ENHANCING THE IN-VIVO EFFICIENCY OF PARTICLE DELIVERY THROUGH NON-COVALENT INTERACTION WITH RED BLOOD CELL SURFACE PROTEINS  
The present invention relates to the production of modified microscale and nanoscale particles that have enhanced in vivo delivery characteristics. The resultant particles can be used in any of a...
US20160322174 METHOD FOR PLASMA ACTIVATION OF BIOCHAR MATERIAL  
A method for using plasma to activate biochar is disclosed where reactive gas(es) are excited by external power; biochar set on a sample holder is electrically biased or set at a floating...
US20160317638 MULTIEPITOPE FUSION ANTIGENS AND VACCINES AND THEIR USE IN TREATMENT OF ENTEROTOXIGENIC DIARRHEA  
Provided herein are polypeptides comprising up to 9 antigenic elements of ETEC virulence determinants: 7 CFA adhesins [CFA/I, CFA/II (CS1, CS2, CS3), CFA/IV (CS4, CS5, CS6)] expressed by the most...
US20160235082 HEAT STABLE WHEY PROTEIN PRODUCTS AND A PROCESS FOR THE PREPARATION OF HEAT STABLE WHEY PROTEINS  
Different versions of heat stable whey protein ingredients can be produced by subjecting whey protein solutions to specific heat treatments in the presence of a specific concentration of hydrogen...
US20160046907 IN VITRO SYSTEM FOR GENERATION OF ANTIGEN-SPECIFIC IMMUNE RESPONSES  
The present invention describes methods to produce vaccines and antibodies, which methods including contacting follicular dendritic cells (FDC) with naïve B-cells to mimic conditions in the...
9233110 Protein nanocarriers for topical delivery  
The invention encompasses nanoparticle assemblies and methods for preparing nanoparticle and compositions comprising such nanoparticles for use in topical or skin applications. The invention...
9220680 Compositions and methods for localized drug delivery through mammary papillae  
The invention provides compositions and methods for the prevention, diagnosis, or treatment of conditions affecting breast tissue. The compositions can include one or more therapeutic agents or...
US20150307360 NOVEL SOLUTION FOR ELECTROPHORETIC DEPOSITION OF NANOPARTICLES INTO THIN FILMS  
The present invention describes a non-aqueous organic solution for Electrophoretic Deposition (EPD) of nanoparticles onto thin films, including method of using said non-aqueous organic solution...
US20150276737 Immunogenic compositions including SIRS virus  
Immunogenic compositions that include swine infertility and respiratory virus (“SRRS virus”) are provided herein. Also provided are kits for producing and using the immunogenic compositions....
US20150150822 NOVEL CORE-SHELL NANOPARTICLES FOR ORAL DRUG DELIVERY  
The invention relates to an oral nanoparticle drug delivery system, including methods for preparing such a system using a hydrophobic water insoluble protein, which nanoparticles may include...
8993303 Genetically engineered cyanobacteria  
The disclosed embodiments provide cyanobacteria spp. that have been genetically engineered to have increased production of carbon-based products of interest. These genetically engineered hosts...
US20140370110 POLYMER CONJUGATED PROTEIN MICELLES  
The invention encompasses micelle assemblies, compositions having micelle assemblies, and methods for preparing micelle assemblies and compositions thereof. The invention also encompasses a...
US20140313574 NANOPARTICLE FILMS FOR USE AS SOLAR CELL BACK REFLECTORS AND OTHER APPLICATIONS  
Disclosed are methods for forming nanoparticle films using electrophoretic deposition. The methods comprise exposing a substrate to a solution, the solution comprising substantially dispersed...
US20140308351 Method of Forming Non-Immunogenic Hydrophobic Protein Nanoparticles, and Uses Therefor  
Methods are described for producing non-immunogenic nanoparticles from protein sources by controlling the pH in a nanoprecipitation process. The nanoparticles that are produced by the disclosed...
US20140234420 Method of Treating Skin Disorders using Nanoscale Delivery Devices and Transdermal Enhancing Compositions  
The present invention describes methods and compositions for treating diverse dermatological conditions, including acne and psoriasis, using zein containing nanocarrier devices for topical...
8771779 Method for reversing an oxidized off-flavor from milk  
A method of reversing the formation of an oxidized off-flavor in milk that includes providing milk, and heating the milk to a temperature between approximately 70° C. and approximately 90° C. for...
US20140162873 MATERIALS AND METHODS FOR PRODUCTION OF ACTIVATED CARBONS  
The invention is directed to improved methods for producing high-quality activated carbons from biochar. The invention also provides materials and methods for creation of activated carbons useful...
8697098 Polymer conjugated protein micelles  
The invention encompasses micelle assemblies, compositions having micelle assemblies, and methods for preparing micelle assemblies and compositions thereof. The invention also encompasses a...
US20140088059 Compositions and Methods for Localized Drug Delivery through Mammary Papillae  
The invention provides compositions and methods for the prevention, diagnosis, or treatment of conditions affecting breast tissue. The compositions can include one or more therapeutic agents or...
US20140073822 Rotating Fluidized Bed Catalytic Pyrolysis Reactor  
Reactors for the pyrolysis of pyrolyzable matter, pyrolysis systems incorporating the reactors and methods of using the reactors are provided. Also provided are systems and methods for integrating...
8669225 Method of forming non-immunogenic hydrophobic protein nanoparticles and uses therefor  
Methods are described for producing non-immunogenic nanoparticles from protein sources by controlling the pH in a nanoprecipitation process. The nanoparticles that are produced by the disclosed...
US20130210654 Multiplex Immune Effector Molecule Assay  
Methods for detecting at least seven cytokines in a porcine biological sample are provided. Also provided are multiplex assay kits that allow for the detection and quantification of the cytokines...
US20130202737 Methods and Composition for EPS-Fortified Ingredients in Cheese  
The present disclosure relates to methods and compositions for preparing cheese products with exopolysaccharide (EPS). In particular, an EPS-producing culture is deactivated either before or...
US20130195930 Inulin and Inulin Acetate Formulations  
The disclosure provides compositions that include microparticles or nanoparticles of beta inulin or inulin acetate and an active agent, where the active agent is contained within individual...
8475864 Method for removing an oxidized off-flavor from milk  
A method of reversing the formation of an oxidized off-flavor in milk that includes providing milk, and heating the milk to a temperature between approximately 70° C. and approximately 90° C. for...
8420101 Vaccine for porcine post-weaning diarrhea caused by enterotoxigenic Escherichia coli  
Vaccines and methods for making and using the same. An example vaccine may be a vaccine against enterotoxigenic Escherichia coli. The vaccine may include an Escherichia coli strain. The...
US20120276637 GENETICALLY ENGINEERED CYANOBACTERIA  
The disclosed embodiments provide cyanobacteria spp. that have been genetically engineered to have increased production of carbon-based products of interest. These genetically engineered hosts...
US20120269842 ENTEROTOXIGENIC E. COLI FUSION PROTEIN VACCINES  
The disclosure relates to fusions of enterotoxigenic Escherichia coli (ETEC) polynucleotides and polypeptides. In one example, a toxiod heat-labile (LT) and heat-stable (STa) fusion is described....
US20120219600 POLYMER CONJUGATED PROTEIN MICELLES  
The invention encompasses micelle assemblies, compositions having micelle assemblies, and methods for preparing micelle assemblies and compositions thereof. The invention also encompasses a...
US20120195947 PROTEIN NANOCARRIERS FOR TOPICAL DELIVERY  
The invention encompasses nanoparticle assemblies and methods for preparing nanoparticle and compositions comprising such nanoparticles for use in topical or skin applications. The invention...
8182984 Recombinant North American type 1 porcine reproductive and respiratory syndrome virus and methods of use  
Porcine reproductive and respiratory syndrome virus (PRRSV) is a major problem in the pork industry worldwide. The inclusion of markers in vaccines will allow for diagnostic differentiation of...
US20120040335 Identification of Porcine Reproductive and Respiratory Syndrome Virus  
An enzyme-linked immunosorbent assay (ELISA) is based on the non-structural protein 7 (nsp7) of porcine reproductive and respiratory syndrome virus (PRRSV) and provides for the simultaneous...
US20110318379 Vaccine for Porcine Post-Weaning Diarrhea Caused by Enterotoxigenic Escherichia Coli  
Vaccines and methods for making and using the same. An example vaccine may be a vaccine against enterotoxigenic Escherichia coli. The vaccine may include an Escherichia coli strain. The...
US20110091565 METHOD OF FORMING NON-IMMUNOGENIC HYDROPHOBIC PROTEIN NANOPARTICLES AND USES THEREFOR  
Methods are described for producing non-immunogenic nanoparticles from protein sources by controlling the pH in a nanoprecipitation process. The nanoparticles that are produced by the disclosed...
7927586 Vaccine for porcine post-weaning diarrhea caused by enterotoxigenic Escherichia coli  
Vaccines and methods for making and using the same. An example vaccine may be a vaccine against enterotoxigenic Escherichia coli. The vaccine may include an Escherichia coli strain. The...
US20110079275 SEMICONDUCTOR NANOPARTICLE/NANOFIBER COMPOSITE ELECTRODES  
Composite electrode materials for DSSCs, DSSCs incorporating the composite electrode materials and methods for making the composite electrode materials are provided. The composite electrode...
US20100323076 Method For Reversing An Oxidized Off-Flavor From Milk  
A method of reversing the formation of an oxidized off-flavor in milk that includes providing milk, and heating the milk to a temperature between approximately 70° C. and approximately 90° C. for...
US20100136047 RECOMBINANT NORTH AMERICAN TYPE 1 PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND METHODS OF USE  
Porcine reproductive and respiratory syndrome virus (PRRSV) is a major problem in the pork industry worldwide. The inclusion of markers in vaccines will allow for diagnostic differentiation of...
US20100008949 VACCINE FOR PORCINE POST-WEANING DIARRHEA CAUSED BY ENTEROTOXIGENIC ESCHERICHIA COLI  
Vaccines and methods for making and using the same. An example vaccine may be a vaccine against enterotoxigenic Escherichia coli. The vaccine may include an Escherichia coli strain. The...
7264804 Kits for detecting anti-SIRS antibodies  
The invention includes kits for producing and using immunogenic compositions that include swine infertility and respiratory virus. The invention also includes vaccines and sera for treatment of...
US20070166735 METHODS OF IN VITRO PROPAGATION AND DETECTION OF INFECTIOUS PRION  
Methods for the in vitro propagation of infectious prions (PrPSc) are provided. Follicular dendritic cells (FDCs) are cultured with B cells and infected with prions. Methods of detecting...
US20070099852 CUCURBITACIN COMPOUNDS  
Cucurbitacins, cucurbitacin derivatives, and methods for making and using the same are provided.
US20070049538 METHODS FOR USING CUCURBITACIN COMPOUNDS  
Cucurbitacins, cucurbitacin derivatives, and methods for making and using the same are provided.
6855315 Kits for detecting swine infertility and respiratory syndrome (SIRS) virus  
The invention includes a vaccine and sera for treatment of Mystery Swine Disease (MSD), a method for producing the vaccine, methods for diagnosis of MSD, a viral agent that will mimic “mystery...
US20040101612 Salt whey product and method of making  
A process for the manufacture of a salt whey product is provided. In the dried form the product contains 35-45% salt and 5-15% whey protein and in the liquid form, over 12% salt and over 30%...
Matches 1 - 50 out of 56 1 2 >